Alaunos Therapeutics (TCRT) Return on Sales [ROS] (2009 - 2026)
Alaunos Therapeutics (TCRT) posted Return on Sales [ROS] of -135266.67% for Q2 2026, down 68000.00 percentage points from -67266.67% a year earlier but up 2900.00 percentage points from the prior quarter.
Powered by 
Analysis
Alaunos Therapeutics (TCRT) Return on Sales [ROS] (2009 - 2026) Analysis & Trends
For FY2025, Alaunos Therapeutics' Return on Sales [ROS] came in at -84500.00%, down 36380.00 percentage points from FY2024.
- Annual Return on Sales [ROS] shows a four-year change of -65112.75 percentage points (FY2021 to FY2025).
- In prior years, Alaunos Therapeutics' Return on Sales [ROS] was -48120.00% in FY2024 (+637220.00 pp), -685340.00% in FY2023 (-684138.60 pp), -1201.40% in FY2022 (+18185.85 pp) and -19387.25% in FY2021.
- Quarterly Return on Sales [ROS] has run from a low of -794900.00% in Q4 2023 to a high of -283.89% in Q3 2022 over five years.
- On a year-over-year basis, Return on Sales [ROS] has declined in each of the last three quarters, with an average year-over-year change of +107370.00 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q4 2024, with a gain of 776025.00 percentage points; the weakest was Q4 2023, with a drop of 717436.36 percentage points.
- According to Business Quant data, Return on Sales [ROS] for the three prior quarters was -138166.67% (Q1 2026), -30233.33% (Q4 2025) and -67883.33% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 32.98% |
| 10 | Alaunos Therapeutics | 4.16 Mn | 357,198.54 | - | -135,266.67% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -135,266.67% |
| Mar 31, 2026 | -138,166.67% |
| Dec 31, 2025 | -30,233.33% |
| Sep 30, 2025 | -67,883.33% |
| Jun 30, 2025 | -67,266.67% |
| Mar 31, 2025 | -54,600.00% |
| Dec 31, 2024 | -18,875.00% |
| Sep 30, 2024 | -200,116.67% |
| Jun 30, 2024 | -29,150.00% |
| Mar 31, 2024 | -174,200.00% |
| Dec 31, 2023 | -794,900.00% |
| Sep 30, 2023 | -232,260.00% |
| Jun 30, 2023 | -199,550.00% |
| Mar 31, 2023 | -1,221.42% |
| Dec 31, 2022 | -77,463.64% |
| Sep 30, 2022 | -283.89% |
| Jun 30, 2022 | -12,916.25% |
| Mar 31, 2022 | -16,267.75% |
| Dec 31, 2021 | -552,550.00% |
| Sep 30, 2021 | -5,602.01% |
API Access
Alaunos Therapeutics Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=TCRT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "TCRT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=TCRT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();